Literature DB >> 25755448

Coffee and liver - long way to go.

Ajay K Duseja1.   

Abstract

Keywords:  CC, Caffeine consumption; CHC, Chronic hepatitis C; HCC, Hepatocellular carcinoma; IQR, interquartile range; LDL, Low-density lipoprotein; NAFLD, Nonalcoholic fatty liver disease; NHANES, National Health and Nutrition Examination Surveys

Year:  2012        PMID： 25755448      PMCID： PMC3940320          DOI： 10.1016/j.jceh.2012.07.006

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


× No keyword cloud information.
  19 in total

Review 1.  Modification of N-acetyltransferases and glutathione S-transferases by coffee components: possible relevance for cancer risk.

Authors:  Wolfgang W Huber; Wolfram Parzefall
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

Review 2.  Review article: possible beneficial effects of coffee on liver disease and function.

Authors:  I S H Cadden; N Partovi; E M Yoshida
Journal:  Aliment Pharmacol Ther       Date:  2007-07-01       Impact factor: 8.171

3.  Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Gastroenterology       Date:  2005-12       Impact factor: 22.682

4.  Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis.

Authors:  Jeffrey W Molloy; Christopher J Calcagno; Christopher D Williams; Frances J Jones; Dawn M Torres; Stephen A Harrison
Journal:  Hepatology       Date:  2011-12-22       Impact factor: 17.425

5.  Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C.

Authors:  Neal D Freedman; Teresa M Curto; Karen L Lindsay; Elizabeth C Wright; Rashmi Sinha; James E Everhart
Journal:  Gastroenterology       Date:  2011-03-02       Impact factor: 22.682

6.  Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2).

Authors:  B J Majer; E Hofer; C Cavin; E Lhoste; M Uhl; H R Glatt; W Meinl; S Knasmüller
Journal:  Food Chem Toxicol       Date:  2005-03       Impact factor: 6.023

7.  Coffee consumption and risk of liver cancer: a meta-analysis.

Authors:  Susanna C Larsson; Alicja Wolk
Journal:  Gastroenterology       Date:  2007-03-24       Impact factor: 22.682

8.  Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways.

Authors:  Olav A Gressner; Birgit Lahme; Katharina Rehbein; Monika Siluschek; Ralf Weiskirchen; Axel M Gressner
Journal:  J Hepatol       Date:  2008-04-30       Impact factor: 25.083

9.  The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism.

Authors:  C Cavin; D Holzhäuser; A Constable; A C Huggett; B Schilter
Journal:  Carcinogenesis       Date:  1998-08       Impact factor: 4.944

10.  The relationship of coffee consumption with mortality.

Authors:  Esther Lopez-Garcia; Rob M van Dam; Tricia Y Li; Fernando Rodriguez-Artalejo; Frank B Hu
Journal:  Ann Intern Med       Date:  2008-06-17       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.